Stock listing
Immunovia Ab
Selected listing: 0G8X · LSE · SEK · GB
Immunovia Ab (LSE:0G8X), Health Technology. Latest release Aug 6, 2026: Immunovia Publishes Interim Report for April-June 2026.
- Ticker
- LSE:0G8X
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- LSE
- Currency
- SEK
Latest news from Immunovia Ab
Immunovia Publishes Interim Report for April-June 2026
August 6, 2026
Immunovia announces new performance data for PancreaSure ahead of upcoming application for Medicare coverage
June 15, 2026
Immunovia publishes final AFFIRM study results in Journal of Clinical Oncology confirming strong diagnostic performance of PancreaSure
June 10, 2026
Immunovia Publishes Interim Report for January-March 2026
May 7, 2026
Immunovia launches ASSURE registry to evaluate real-world clinical impact of PancreaSure in high-risk pancreatic cancer surveillance
May 5, 2026
Events
Research Immunovia Ab
Alternate listings
IMMNOV:OMXSTO
SE · SEK
Alternate listing for Immunovia Ab; the primary context on this page is 0G8X:LSE.
1YR:GETTEX
DE · EUR
Alternate listing for Immunovia Ab; the primary context on this page is 0G8X:LSE.
IMMNOS:AQUISEU
GB · SEK
Alternate listing for Immunovia Ab; the primary context on this page is 0G8X:LSE.
IMMNOS:AQUISUK
GB · SEK
Alternate listing for Immunovia Ab; the primary context on this page is 0G8X:LSE.
1YR:FWB
DE · EUR
Alternate listing for Immunovia Ab; the primary context on this page is 0G8X:LSE.
1YR:MUN
DE · EUR
Alternate listing for Immunovia Ab; the primary context on this page is 0G8X:LSE.
IMMVF:OTC
US · USD
Alternate listing for Immunovia Ab; the primary context on this page is 0G8X:LSE.